Sun Pharma receives warning letter from USFDA

Chennai, Dec 19 (IANS) Drug major Sun Pharmacuetical Industries Ltd on Saturday said it has received a warning letter from USFDA relating to its facility in Halol in Gujarat.

The letter was a result of the inspection done by the US Food and Drug Administration (USFDA) at Halol plant in September 2014.

In a statement Sun Pharma said it would respond to the warning letter with a detailed plan within the stipulated timeframe.

“While our team is working hard to ensure that the commitments made to the USFDA in September 2014 are fully completed, we will continue to cooperate with the USFDA and undertake any additional steps necessary to ensure that the US agency is completely satisfied with our remediation of the Halol facility,” Dilip Shanghvi, managing director, was quoted as saying in the statement.

Post the September 2014 inspection, the USFDA has withheld future product approvals from the Halol facility.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of or any employee thereof. is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here